BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 22095958)

  • 1. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.
    Lieberman BP; Ploessl K; Wang L; Qu W; Zha Z; Wise DR; Chodosh LA; Belka G; Thompson CB; Kung HF
    J Nucl Med; 2011 Dec; 52(12):1947-55. PubMed ID: 22095958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alanine and glycine conjugates of (2S,4R)-4-[
    Zha Z; Ploessl K; Lieberman BP; Wang L; Kung HF
    Nucl Med Biol; 2018 May; 60():19-28. PubMed ID: 29525446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents.
    Ploessl K; Wang L; Lieberman BP; Qu W; Kung HF
    J Nucl Med; 2012 Oct; 53(10):1616-24. PubMed ID: 22935578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors.
    Qu W; Oya S; Lieberman BP; Ploessl K; Wang L; Wise DR; Divgi CR; Chodosh LA; Thompson CB; Kung HF
    J Nucl Med; 2012 Jan; 53(1):98-105. PubMed ID: 22173839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Imaging of Glutamine in Cancer.
    Zhu L; Ploessl K; Zhou R; Mankoff D; Kung HF
    J Nucl Med; 2017 Apr; 58(4):533-537. PubMed ID: 28232608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[
    Pollard AC; Paolillo V; Radaram B; Qureshy S; Li L; Maity T; Wang L; Uddin MN; Wood CG; Karam JA; Pagel MD; Piwnica-Worms D; Millward SW; Fowlkes NW; Norton W; Engel BJ; Pisaneschi F; Zacharias NM
    Mol Imaging Biol; 2022 Dec; 24(6):959-972. PubMed ID: 35732988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET Imaging of
    Liu F; Xu X; Zhu H; Zhang Y; Yang J; Zhang L; Li N; Zhu L; Kung HF; Yang Z
    Mol Pharm; 2018 Aug; 15(8):3448-3455. PubMed ID: 29985631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.
    Wu Z; Zha Z; Li G; Lieberman BP; Choi SR; Ploessl K; Kung HF
    Mol Pharm; 2014 Nov; 11(11):3852-66. PubMed ID: 25095908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of
    Dunphy MPS; Harding JJ; Venneti S; Zhang H; Burnazi EM; Bromberg J; Omuro AM; Hsieh JJ; Mellinghoff IK; Staton K; Pressl C; Beattie BJ; Zanzonico PB; Gerecitano JF; Kelsen DP; Weber W; Lyashchenko SK; Kung HF; Lewis JS
    Radiology; 2018 May; 287(2):667-675. PubMed ID: 29388903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (2S, 4R)-4-[
    Miner MW; Liljenbäck H; Virta J; Merisaari J; Oikonen V; Westermarck J; Li XG; Roivainen A
    Mol Imaging Biol; 2020 Aug; 22(4):969-978. PubMed ID: 31993927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2
    Palani S; Miner MWG; Virta J; Liljenbäck H; Eskola O; Örd T; Ravindran A; Kaikkonen MU; Knuuti J; Li XG; Saraste A; Roivainen A
    Front Immunol; 2022; 13():821423. PubMed ID: 35145523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[
    Li C; Huang S; Guo J; Wang C; Huang Z; Huang R; Liu L; Liang S; Wang H
    Mol Imaging Biol; 2019 Dec; 21(6):1117-1126. PubMed ID: 30850970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Zhou R; Pantel AR; Li S; Lieberman BP; Ploessl K; Choi H; Blankemeyer E; Lee H; Kung HF; Mach RH; Mankoff DA
    Cancer Res; 2017 Mar; 77(6):1476-1484. PubMed ID: 28202527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (2S,4R)-4-[
    Zhu H; Liu F; Zhang Y; Yang J; Xu X; Guo X; Liu T; Li N; Zhu L; Kung HF; Yang Z
    Mol Imaging Biol; 2019 Oct; 21(5):945-953. PubMed ID: 30793240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of (2S,4S)-4-[
    Huang Y; Liu Y; Li C; Li Z; Chen H; Zhang L; Liang Y; Wu Z
    Mol Pharm; 2023 Oct; 20(10):5195-5205. PubMed ID: 37647563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side Chain Optimization Remarkably Enhances the in Vivo Stability of
    Chen J; Li C; Hong H; Liu H; Wang C; Xu M; Han Y; Liu Z
    Mol Pharm; 2019 Dec; 16(12):5035-5041. PubMed ID: 31670970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative enzymology of (2S,4R)4-fluoroglutamine and (2S,4R)4-fluoroglutamate.
    Cooper AJ; Krasnikov BF; Pinto JT; Kung HF; Li J; Ploessl K
    Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):108-20. PubMed ID: 22613816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine.
    Xu X; Zhu H; Liu F; Zhang Y; Yang J; Zhang L; Zhu L; Li N; Kung HF; Yang Z
    Clin Nucl Med; 2018 Nov; 43(11):e392-e399. PubMed ID: 30179907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic Modeling of
    Viswanath V; Zhou R; Lee H; Li S; Cragin A; Doot RK; Mankoff DA; Pantel AR
    J Nucl Med; 2021 Aug; 62(8):1154-1162. PubMed ID: 33277391
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.